ACXP (STOCKS)
Acurx Pharmaceuticals, Inc. Common Stock
$2.880000
+0.270000 (+10.34%)
Prev close: $2.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David P. Luci
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8.34M
- Employees
- 4
- P/E (TTM)
- -0.44
- P/B (TTM)
- 1.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.31 | $-1.01 | +0.7049 | +69.46% |
|
Sep 2025 (Q3)
|
$-1.23 | $-1.34 | +0.1062 | +7.95% |
|
Jun 2025 (Q2)
|
$-1.89 | $-2.31 | +0.4219 | +18.25% |
|
Mar 2025 (Q1)
|
$-2.20 | $-3.06 | +0.8600 | +28.10% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $8.09M |
| Research and Development | $1.83M |
| Other Operating Expenses | $6.26M |
| Operating Income/Loss | -$8.09M |
| Income/Loss From Continuing Operations After Tax | -$7.97M |
| Income/Loss From Continuing Operations Before Tax | -$7.97M |
| Net Income/Loss | -$7.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.32 |
| Diluted Earnings Per Share | -$5.32 |
| Basic Average Shares | 1,498,793 |
| Diluted Average Shares | 1,498,793 |
| Assets | $7.69M |
| Current Assets | $7.69M |
| Prepaid Expenses | $85.02K |
| Other Current Assets | $7.60M |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.42M |
| Current Liabilities | $2.42M |
| Wages | $39.01K |
| Other Current Liabilities | $2.38M |
| Noncurrent Liabilities | $0.00 |
| Equity | $5.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.27M |
| Liabilities And Equity | $7.69M |
| Net Cash Flow From Operating Activities | -$6.79M |
| Net Cash Flow From Operating Activities, Continuing | -$6.79M |
| Net Cash Flow From Investing Activities | -$3.85M |
| Net Cash Flow From Investing Activities, Continuing | -$3.85M |
| Net Cash Flow From Financing Activities | $10.64M |
| Net Cash Flow From Financing Activities, Continuing | $10.64M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$7.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.97M |
| Other Comprehensive Income/Loss | $0.00 |